logo
logo
Sign in

Ventricular Assist Devices Market Is Estimated To Witness High Growth Owing To Rising Prevalence of Heart Failure & Technological Advancements

avatar
Gauri Cmi
  Ventricular Assist Devices Market Is Estimated To Witness High Growth Owing To Rising Prevalence of Heart Failure & Technological Advancements


The Ventricular Assist Devices Market is estimated to be valued at US$ 1.15 billion in 2023 and is expected to exhibit a CAGR of 10.8%  over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Ventricular assist devices (VADs) are mechanical pumps that are used to support the pumping function of the heart in patients with severe heart failure. These devices are typically implanted into the chest or abdomen and help to improve blood flow and oxygenation in the body. VADs have become an essential therapeutic option for patients who are ineligible for heart transplantation or who are awaiting a transplant. Additionally, advancements in VAD technology have led to the development of smaller, more portable devices, thereby enhancing patient mobility and quality of life.

Market Dynamics:

The Ventricular Assist Devices market is driven by several factors. Firstly, the rising prevalence of heart failure, attributed to an aging population and sedentary lifestyles, is fueling the demand for VADs. Secondly, significant technological advancements in VADs, such as the development of continuous flow pumps, have improved device reliability and patient outcomes. Furthermore, increasing investments in research and development activities to enhance device design and functionality are expected to drive market growth. However, high device costs and the risk of adverse events associated with VAD implantation are factors that may hinder market growth to some extent. Nonetheless, the growing adoption of VADs as a bridge to heart transplant and destination therapy options presents considerable opportunities for market players in the coming years.

Segment Analysis:

The ventricular assist devices market can be segmented based on product type, indication, and end-user. In terms of product type, the dominating segment is the left ventricular assist devices (LVADs). LVADs are widely used to support patients with advanced heart failure and are preferred due to their ability to improve blood flow and enhance overall cardiac function.

In terms of indication, the dominating segment is bridge-to-transplantation (BTT). This segment is dominant because BTT therapy provides temporary support to patients awaiting heart transplant, allowing them to survive until a suitable donor heart becomes available. The BTT segment is expected to witness significant growth due to the increasing prevalence of heart failure and the growing demand for heart transplant surgeries.

In terms of end-user, the dominating segment is hospitals. Hospitals are the primary healthcare facilities where ventricular assist devices are implanted and managed. The advanced infrastructure and specialized medical expertise available in hospitals make them the preferred choice for device implantation and subsequent patient care.

PEST Analysis:

Political: The political landscape plays a crucial role in the Ventricular Assist Devices Market Scope. Government regulations and policies related to healthcare infrastructure, reimbursement, and procurement procedures can impact the adoption of ventricular assist devices. Changes in healthcare policies and regulations can either facilitate or hinder the growth of the market.

Economic: The economic factors influencing the ventricular assist devices market include healthcare expenditure, GDP growth, and healthcare insurance coverage. Rising healthcare expenditure, along with growing per capita income, is expected to drive the market. Moreover, the availability of healthcare insurance coverage for ventricular assist devices can further boost market growth.

Social: The social factors influencing the market include the aging population, increasing prevalence of cardiovascular diseases, and awareness about advanced treatment options. As the global population ages and the incidence of cardiovascular diseases rises, the demand for ventricular assist devices is expected to increase. Additionally, the increasing awareness about the benefits of ventricular assist devices among patients and healthcare professionals will propel market growth.

Technological: Technological advancements play a pivotal role in the ventricular assist devices market. Innovations in device design, miniaturization, wireless monitoring, and battery life have improved patient outcomes and expanded the application of these devices. Furthermore, the integration of artificial intelligence and predictive analytics in ventricular assist devices has enhanced their accuracy and efficiency.

Key Takeaways:

The global ventricular assist devices market is expected to witness high growth, exhibiting a CAGR of 10.8%  over the forecast period (2023-2030), due to increasing prevalence of heart failure and advancements in device technology. The market is projected to reach a size of US$ 1.15 billion by 2023.

Regionally, North America is the fastest-growing and dominating region in the ventricular assist devices market. The well-established healthcare infrastructure, increasing prevalence of cardiovascular diseases, and high adoption of advanced medical technologies are the key factors contributing to the growth of the market in this region.

 

Read More: https://www.ukwebwire.com/ventricular-assist-devices-market-size-and-share/


collect
0
avatar
Gauri Cmi
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more